[{"Title":"Довідкові матеріали","UniqueID":"v99307683_uk","Index":1.0,"Summary":"

1. FDA Adverse Event Reporting System (FAERS). Public Dashboard, Database and Questions and Answers on FDA's Adverse Event Reporting System (FAERS). Accessed March 4, 2025.

","HeadType":"G_Head","SchemeItemProp":"","Children":[]},{"Title":"Класифікація","UniqueID":"v99307692_uk","Index":2.0,"Summary":"

There are various causes, clinical manifestations, and outcomes of ADRs. One classification system categorizes ADRs into 6 types ( 1 ):

","HeadType":"F_Head","SchemeItemProp":"itemprop=\"cause\" itemscope itemtype=\"http://schema.org/MedicalCause\"","Children":[{"Title":"Довідковий матеріал щодо класифікації","UniqueID":"v99307718_uk","Index":1.0,"Summary":"

There are various causes, clinical manifestations, and outcomes of ADRs. One classification system categorizes ADRs into 6 types ( 1 ):

","HeadType":"G_Head","SchemeItemProp":"itemprop=\"cause\" itemscope itemtype=\"http://schema.org/MedicalCause\"","Children":[]}]},{"Title":"Фактори ризику","UniqueID":"v99307724_uk","Index":3.0,"Summary":"

Incidence and severity of ADRs vary by patient characteristics (eg, age, sex, ethnicity, coexisting disorders, genetic or geographic factors) and by characteristics of the medication (eg, type of medication, route of administration , dosage, bioavailability , treatment duration). Risk is higher in older adults and with polypharmacy. The contribution of prescription errors by prescribers and poor adherence by patients to the prescribed drug regimen to the incidence of ADRs is unclear.

","HeadType":"F_Head","SchemeItemProp":"","Children":[]},{"Title":"Довідкові матеріали щодо факторів ризику","UniqueID":"v99307747_uk","Index":4.0,"Summary":"

1. Schatz SN, Weber RJ. (2015) Adverse Drug Reactions. In: Lee MW and Murphy JE, Eds., PSAP 2015 Book 2 CNS/Pharmacy Practice, American College of Clinical Pharmacy, Lenexa, 5-26.

","HeadType":"G_Head","SchemeItemProp":"","Children":[]},{"Title":"Симптоми та ознаки","UniqueID":"v99307759_uk","Index":5.0,"Summary":"

Symptoms and signs may manifest soon after the first dose or only after a delay or with chronic use. They may obviously result from the drug or be too subtle to identify as related to a specific drug.

","HeadType":"F_Head","SchemeItemProp":"itemprop=\"signOrSymptom\" itemscope itemtype=\"http://schema.org/MedicalSignOrSymptom\"","Children":[]},{"Title":"Діагностика","UniqueID":"v99307765_uk","Index":6.0,"Summary":"

History and physical examination

","HeadType":"F_Head","SchemeItemProp":"","Children":[]},{"Title":"Лікування","UniqueID":"v99307782_uk","Index":7.0,"Summary":"

Discontinuation of drug, if necessary

","HeadType":"F_Head","SchemeItemProp":"itemprop=\"possibleTreatment\" itemscope itemtype=\"http://schema.org/MedicalTherapy\"","Children":[]},{"Title":"Профілактика","UniqueID":"v99307798_uk","Index":8.0,"Summary":"

Prevention of adverse drug reactions (ADRs) requires familiarity with the medication and potential reactions to it. Many causes of ADRs are preventable (see Preventable Causes of Drug-Related Problems.)

","HeadType":"F_Head","SchemeItemProp":"","Children":[{"Title":"Довідкові матеріали щодо профілактики","UniqueID":"v99307812_uk","Index":1.0,"Summary":"

","HeadType":"G_Head","SchemeItemProp":"","Children":[]}]}]